Balancing Affordability and Growth in Pharma: India's Pricing Strategy

Union Chemicals and Fertilizers Minister J P Nadda emphasized the government's commitment to making essential medicines affordable while promoting industry growth. Addressing Rajya Sabha, he highlighted the ongoing evaluation of the National Pharmaceutical Pricing Policy and Drug Prices Control Order to ensure accessibility, affordability, and industry innovation.


Devdiscourse News Desk | New Delhi | Updated: 03-02-2026 16:22 IST | Created: 03-02-2026 16:22 IST
Balancing Affordability and Growth in Pharma: India's Pricing Strategy
  • Country:
  • India

Union Chemicals and Fertilizers Minister J P Nadda announced the government's efforts to make essential medications affordable, focusing on balancing pricing policy with industry growth. Speaking at Rajya Sabha, Nadda stressed the aim to create an equilibrium between the pricing of essential drugs and industry development.

The minister assured that robust drug and pricing policies are in place, with ongoing price regulation being a continuous endeavor. He outlined the government's strategy to ensure medicines are accessible and affordable, while also fostering industry innovation and employment opportunities.

Nadda highlighted ongoing consultations with stakeholders to assess policy relevance, with feedback influencing potential reforms. Through mechanisms like the National Health Mission and Jan Aushadhi Kendras, the government aims to provide medicines and reduce out-of-pocket expenses, which have significantly decreased over the last decade.

TRENDING

DevShots

Latest News

OPINION / BLOG / INTERVIEW

Generative AI literacy gaps threaten responsible and sustainable AI use

Blockchain electronic voting faces major legal and usability barriers

Wearable and implantable sensors drive shift toward continuous health monitoring

AI companion chatbots may ease loneliness for autistic users but carry ethical risks

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback